| The transcription factor NF-YA is crucial for neural progenitor maintenance during brain development T Yamanaka, M Kurosawa, A Yoshida, T Shimogori, A Hiyama, SN Maity, ... Journal of Biological Chemistry 300 (2), 2024 | | 2024 |
| Mesenchymal and stem-like prostate cancer linked to therapy-induced lineage plasticity and metastasis H Han, Y Wang, J Curto, S Gurrapu, S Laudato, A Rumandla, ... Cell reports 39 (1), 2022 | 28 | 2022 |
| In-vitro Effects of Chlorpyrifos and Monocrotophos on the activity of acetylcholinesterase (AChE) in different tissues of Apple Snail Pila globosa (Swainson, 1822) S Pal, S Maity, S Balachandran, S Chaudhury Nature Environment and Pollution Technology 20 (3), 1263-1268, 2021 | 3 | 2021 |
| Transcriptional Inactivation of TP53 and the BMP Pathway Mediates Therapy-induced Dedifferentiation and Metastasis in Prostate Cancer H Han, Y Wang, J Curto, S Gurrapu, S Laudato, A Rumandla, ... bioRxiv, 2021.04. 14.439569, 2021 | | 2021 |
| Gene expression profiling in neuronal cells identifies a different type of transcriptome modulated by NF-Y T Yamanaka, H Miyazaki, A Tosaki, SN Maity, T Shimogori, N Hattori, ... Scientific reports 10 (1), 21714, 2020 | 5 | 2020 |
| Androgen receptor blockade induces reprogramming to mesenchymal and stem-like prostate cancer and dependency on HER2/3 signaling. H Han, Y Wang, A Rumandla, S Laudato, JC Navarro, S Gurrapu, ... CANCER RESEARCH 80 (11), 31-32, 2020 | | 2020 |
| Targeting cancer stem-cells in aggressive variant prostate cancers R Soundararajan, P Allegakoen, P Hollander, A Paranjape, R Joseph, ... Cancer Research 79 (13_Supplement), 4674-4674, 2019 | 1 | 2019 |
| LncRNA-p21 alters the antiandrogen enzalutamide-induced prostate cancer neuroendocrine differentiation via modulating the EZH2/STAT3 signaling J Luo, K Wang, S Yeh, Y Sun, L Liang, Y Xiao, W Xu, Y Niu, L Cheng, ... Nature communications 10 (1), 2571, 2019 | 149 | 2019 |
| Androgen Receptor Signaling in Castration-Resistant Prostate Cancer Alters Hyperpolarized Pyruvate to Lactate Conversion and Lactate Levels In Vivo N Zacharias, J Lee, S Ramachandran, S Shanmugavelandy, J McHenry, ... Molecular Imaging and Biology 21, 86-94, 2019 | 22 | 2019 |
| Large expert-curated database for benchmarking document similarity detection in biomedical literature search Z Zeineb, P Brown, AC Tan, MA El-Esawi, T Liehr, O Blanck, DP Gladue, ... | | 2019 |
| Large expert-curated database for benchmarking document similarity detection in biomedical literature search P Brown, AC Tan, MA El-Esawi, T Liehr, O Blanck, DP Gladue, ... Database 2019, 2019 | 36 | 2019 |
| EMT, stemness and tumor plasticity in aggressive variant neuroendocrine prostate cancers R Soundararajan, AN Paranjape, S Maity, A Aparicio, SA Mani Biochimica et Biophysica Acta (BBA)-Reviews on Cancer 1870 (2), 229-238, 2018 | 56 | 2018 |
| Frequent PTEN loss and differential HER2/PI3K signaling pathway alterations in salivary duct carcinoma: Implications for targeted therapy P Saintigny, Y Mitani, KB Pytynia, R Ferrarotto, DB Roberts, RS Weber, ... Cancer 124 (18), 3693-3705, 2018 | 30 | 2018 |
| Function of tumor suppressors in resistance to antiandrogen therapy and luminal epithelial plasticity of aggressive variant neuroendocrine prostate cancers R Soundararajan, AM Aparicio, CJ Logothetis, SA Mani, SN Maity Frontiers in Oncology 8, 69, 2018 | 10 | 2018 |
| Abstract A065: Modulating a cancer stem cell-specific signaling pathway to reverse the course of neuroendocrine prostate cancer R Soundararajan, A Paranjape, R Joseph, N Bhangre, A Aparicio, S Maity, ... Molecular Cancer Therapeutics 17 (1_Supplement), A065-A065, 2018 | | 2018 |
| Endothelial-to-osteoblast conversion generates osteoblastic metastasis of prostate cancer SC Lin, YC Lee, G Yu, CJ Cheng, X Zhou, K Chu, M Murshed, NT Le, ... Developmental cell 41 (5), 467-480. e3, 2017 | 80 | 2017 |
| NF-Y (CBF) regulation in specific cell types and mouse models SN Maity Biochimica et Biophysica Acta (BBA)-Gene Regulatory Mechanisms 1860 (5), 598-603, 2017 | 36 | 2017 |
| Targeting DNA damage response in prostate cancer by inhibiting androgen receptor-CDC6-ATR-Chk1 signaling S Karanika, T Karantanos, L Li, J Wang, S Park, G Yang, X Zuo, JH Song, ... Cell reports 18 (8), 1970-1981, 2017 | 82 | 2017 |
| Inhibition of FOXC2 restores epithelial phenotype and drug sensitivity in prostate cancer cells with stem-cell properties AN Paranjape, R Soundararajan, SJ Werden, R Joseph, JH Taube, H Liu, ... Oncogene 35 (46), 5963-5976, 2016 | 90 | 2016 |
| Targeting of CYP17A1 lyase by VT-464 inhibits adrenal and intratumoral androgen biosynthesis and tumor growth of castration resistant prostate cancer SN Maity, MA Titus, R Gyftaki, G Wu, JF Lu, S Ramachandran, ... Scientific reports 6 (1), 35354, 2016 | 33 | 2016 |
